methylprednisolone has been researched along with sphingosine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, A; Hirata, D; Iwamoto, M; Kamimura, T; Kano, S; Kobayashi, E; Masuyama, J; Minota, S; Okazaki, H; Sato, H; Yoshio, T | 1 |
| Allenberg, JR; Böckler, D; Klemm, K; Ryschich, E; Schmidt, J; Schumacher, H; Zhang, J | 1 |
| Giese, T; Meuer, S; Morath, C; Sommerer, C; Zeier, M | 1 |
| Havla, J; Hohlfeld, R; Kümpfel, T | 1 |
| Baumgartner, A; Gross, CM; Rauer, S; Stich, O | 1 |
| Berenguer-Ruiz, L; Feliu-Rey, E; Sempere, AP | 1 |
| Chang, JH; Hsu, CW; Hsu, SC; Hsu, YP; Huang, SK; Huang, WC; Liu, CT | 1 |
1 review(s) available for methylprednisolone and sphingosine
| Article | Year |
|---|---|
[2012: Update on diagnosis and treatment of multiple sclerosis].
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Brain; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Fingolimod Hydrochloride; Glatiramer Acetate; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Interferon-beta; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasmapheresis; Propylene Glycols; Pulse Therapy, Drug; Sphingosine; Spinal Cord | 2012 |
1 trial(s) available for methylprednisolone and sphingosine
| Article | Year |
|---|---|
Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial): Study protocol for a randomized, placebo-controlled trial.
Topics: Adjuvants, Pharmaceutic; Adult; Biomarkers; Clinical Protocols; Community-Acquired Infections; Double-Blind Method; Female; Glucocorticoids; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Lysophospholipids; Male; Methylprednisolone; Pneumonia; Sphingosine | 2019 |
5 other study(ies) available for methylprednisolone and sphingosine
| Article | Year |
|---|---|
Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Apoptosis; Bone Marrow Cells; Cells, Cultured; Disease Models, Animal; DNA; Female; Fingolimod Hydrochloride; Flow Cytometry; Immunoglobulin G; Immunosuppressive Agents; Interleukin-2; Kidney Glomerulus; Longevity; Lupus Erythematosus, Systemic; Lymphoid Tissue; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Propylene Glycols; Sphingosine; T-Lymphocytes | 2002 |
Impaired Fas-induced apoptosis of T lymphocytes in patients with abdominal aortic aneurysms.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Aortic Aneurysm, Abdominal; Apoptosis; Atherosclerosis; Autoimmunity; Down-Regulation; fas Receptor; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Sphingosine; T-Lymphocytes | 2007 |
Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
Topics: Cyclosporine; Fingolimod Hydrochloride; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Kidney Transplantation; Lymphocyte Activation; Lymphopenia; Methylprednisolone; NFATC Transcription Factors; Propylene Glycols; RNA, Messenger; Sphingosine; T-Lymphocytes | 2008 |
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Topics: Adult; Anti-Inflammatory Agents; Brain; Fingolimod Hydrochloride; Herpes Zoster; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Propylene Glycols; Sphingosine | 2012 |
Rebound of disease activity during pregnancy after withdrawal of fingolimod.
Topics: Adult; Anti-Inflammatory Agents; Disability Evaluation; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Pregnancy; Pregnancy Complications; Propylene Glycols; Sphingosine | 2013 |